Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12208 | 924 | 32.6 | 77% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
171 | 3 | MONASCUS//CITRININ//MONASCUS PURPUREUS | 58457 |
43 | 2 | JOURNAL OF LIPID RESEARCH//HDL//LIPOPROTEINS | 30963 |
12208 | 1 | FRIEDEWALD FORMULA//NON HDL CHOLESTEROL//NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL | 924 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | FRIEDEWALD FORMULA | authKW | 720595 | 3% | 84% | 26 |
2 | NON HDL CHOLESTEROL | authKW | 669120 | 5% | 45% | 45 |
3 | NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL | authKW | 497591 | 3% | 47% | 32 |
4 | MIKE ROSENBLOOM CARDIOVASC | address | 495925 | 4% | 37% | 41 |
5 | NON HDL C | authKW | 406514 | 2% | 53% | 23 |
6 | APOLIPOPROTEIN B | authKW | 261800 | 10% | 9% | 93 |
7 | FRIEDEWALD EQUATION | authKW | 236033 | 1% | 71% | 10 |
8 | APOB APOA I RATIO | authKW | 211488 | 1% | 80% | 8 |
9 | BETA QUANTIFICATION | authKW | 202402 | 1% | 88% | 7 |
10 | APOB | authKW | 198321 | 4% | 15% | 41 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Medical Laboratory Technology | 20380 | 25% | 0% | 228 |
2 | Cardiac & Cardiovascular System | 3422 | 25% | 0% | 227 |
3 | Peripheral Vascular Diseases | 2267 | 15% | 0% | 139 |
4 | Endocrinology & Metabolism | 721 | 12% | 0% | 109 |
5 | Medicine, General & Internal | 517 | 12% | 0% | 114 |
6 | Medicine, Research & Experimental | 153 | 6% | 0% | 55 |
7 | Nutrition & Dietetics | 116 | 4% | 0% | 33 |
8 | Pathology | 17 | 2% | 0% | 18 |
9 | Pharmacology & Pharmacy | 15 | 5% | 0% | 48 |
10 | Geriatrics & Gerontology | 11 | 1% | 0% | 8 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MIKE ROSENBLOOM CARDIOVASC | 495925 | 4% | 37% | 41 |
2 | LIPID REFERENCE | 134930 | 1% | 58% | 7 |
3 | CANC CONTROL HLTH PROMOT | 74351 | 0% | 75% | 3 |
4 | CRMLN LIPID REFERENCE | 74351 | 0% | 75% | 3 |
5 | ENDCRINOL DIABET | 66091 | 0% | 100% | 2 |
6 | JULES THORNE | 44059 | 0% | 67% | 2 |
7 | URAC 34 | 44059 | 0% | 67% | 2 |
8 | CORE CLIN STUDIES | 44055 | 0% | 33% | 4 |
9 | ALLAN D MIKE ROSENBLOOM CARDIOVASC | 33045 | 0% | 100% | 1 |
10 | AMBULATORIO CARE PREVENT | 33045 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CLINICAL LIPIDOLOGY | 85384 | 4% | 6% | 41 |
2 | CLINICAL CHEMISTRY | 23219 | 10% | 1% | 91 |
3 | ATHEROSCLEROSIS | 8050 | 6% | 0% | 51 |
4 | JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS | 7556 | 2% | 1% | 16 |
5 | CLINICAL BIOCHEMISTRY | 7417 | 4% | 1% | 34 |
6 | CLINICAL LIPIDOLOGY | 5521 | 1% | 2% | 8 |
7 | LIPIDS IN HEALTH AND DISEASE | 4901 | 2% | 1% | 15 |
8 | CLINICA CHIMICA ACTA | 3424 | 4% | 0% | 34 |
9 | CURRENT OPINION IN LIPIDOLOGY | 2476 | 1% | 1% | 10 |
10 | AMERICAN JOURNAL OF CARDIOLOGY | 2138 | 5% | 0% | 42 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FRIEDEWALD FORMULA | 720595 | 3% | 84% | 26 | Search FRIEDEWALD+FORMULA | Search FRIEDEWALD+FORMULA |
2 | NON HDL CHOLESTEROL | 669120 | 5% | 45% | 45 | Search NON+HDL+CHOLESTEROL | Search NON+HDL+CHOLESTEROL |
3 | NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL | 497591 | 3% | 47% | 32 | Search NON+HIGH+DENSITY+LIPOPROTEIN+CHOLESTEROL | Search NON+HIGH+DENSITY+LIPOPROTEIN+CHOLESTEROL |
4 | NON HDL C | 406514 | 2% | 53% | 23 | Search NON+HDL+C | Search NON+HDL+C |
5 | APOLIPOPROTEIN B | 261800 | 10% | 9% | 93 | Search APOLIPOPROTEIN+B | Search APOLIPOPROTEIN+B |
6 | FRIEDEWALD EQUATION | 236033 | 1% | 71% | 10 | Search FRIEDEWALD+EQUATION | Search FRIEDEWALD+EQUATION |
7 | APOB APOA I RATIO | 211488 | 1% | 80% | 8 | Search APOB+APOA+I+RATIO | Search APOB+APOA+I+RATIO |
8 | BETA QUANTIFICATION | 202402 | 1% | 88% | 7 | Search BETA+QUANTIFICATION | Search BETA+QUANTIFICATION |
9 | APOB | 198321 | 4% | 15% | 41 | Search APOB | Search APOB |
10 | LDL P | 137688 | 1% | 83% | 5 | Search LDL+P | Search LDL+P |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GAROUFI, A , DRAKATOS, A , TSENTIDIS, C , KLINAKI, E , PARASKAKIS, I , MARMARINOS, A , GOURGIOTIS, D , (2017) COMPARING CALCULATED LDL-C WITH DIRECTLY MEASURED LDL-C IN HEALTHY AND IN DYSLIPIDEMIC CHILDREN.CLINICAL BIOCHEMISTRY. VOL. 50. ISSUE 1-2. P. 16 -22 | 38 | 95% | 0 |
2 | NAUCK, M , WARNICK, GR , RIFAI, N , (2002) METHODS FOR MEASUREMENT OF LDL-CHOLESTEROL: A CRITICAL ASSESSMENT OF DIRECT MEASUREMENT BY HOMOGENEOUS ASSAYS VERSUS CALCULATION.CLINICAL CHEMISTRY. VOL. 48. ISSUE 2. P. 236 -254 | 56 | 68% | 126 |
3 | SNIDERMAN, AD , TOTH, PP , THANASSOULIS, G , FURBERG, CD , (2016) AN EVIDENCE-BASED ANALYSIS OF THE NATIONAL LIPID ASSOCIATION RECOMMENDATIONS CONCERNING NON-HDL-C AND APOB.JOURNAL OF CLINICAL LIPIDOLOGY. VOL. 10. ISSUE 5. P. 1248 -1258 | 40 | 68% | 0 |
4 | WALLDIUS, G , JUNGNER, I , (2006) THE APOB/APOA-I RATIO: A STRONG, NEW RISK FACTOR FOR CARDIOVASCULAR DISEASE AND A TARGET FOR LIPID-LOWERING THERAPY - A REVIEW OF THE EVIDENCE.JOURNAL OF INTERNAL MEDICINE. VOL. 259. ISSUE 5. P. 493-519 | 55 | 49% | 163 |
5 | CONTOIS, JH , WARNICK, GR , SNIDERMAN, AD , (2011) RELIABILITY OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL, NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, AND APOLIPOPROTEIN B MEASUREMENT.JOURNAL OF CLINICAL LIPIDOLOGY. VOL. 5. ISSUE 4. P. 264-272 | 31 | 84% | 37 |
6 | MEEUSEN, JW , DONATO, LJ , JAFFE, AS , (2016) SHOULD APOLIPOPROTEIN B REPLACE LDL CHOLESTEROL AS THERAPEUTIC TARGETS ARE LOWERED?.CURRENT OPINION IN LIPIDOLOGY. VOL. 27. ISSUE 4. P. 359 -366 | 43 | 61% | 0 |
7 | SNIDERMAN, AD , WILLIAMS, K , CONTOIS, JH , MONROE, HM , MCQUEEN, MJ , DE GRAAF, J , FURBERG, CD , (2011) A META-ANALYSIS OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL, NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, AND APOLIPOPROTEIN B AS MARKERS OF CARDIOVASCULAR RISK.CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES. VOL. 4. ISSUE 3. P. 337-U144 | 25 | 69% | 146 |
8 | FARNIER, M , GUYTON, JR , JENSEN, E , POLIS, AB , JOHNSON-LEVONAS, AO , BRUDI, P , (2013) EFFECTS OF EZETIMIBE, SIMVASTATIN AND EZETIMIBE/SIMVASTATIN ON CORRELATIONS BETWEEN APOLIPOPROTEIN B, LDL CHOLESTEROL AND NON-HDL CHOLESTEROL IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA.ATHEROSCLEROSIS. VOL. 229. ISSUE 2. P. 415-422 | 28 | 76% | 6 |
9 | BAIRAKTARI, ET , SEFERIADIS, KI , ELISAF, MS , (2005) EVALUATION OF METHODS FOR THE MEASUREMENT OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS. VOL. 10. ISSUE 1. P. 45 -54 | 44 | 59% | 27 |
10 | WALLDIUS, G , JUNGNER, I , (2007) IS THERE A BETTER MARKER OF CARDIOVASCULAR RISK THAN LDL CHOLESTEROL? APOLIPOPROTEINS B AND A-I - NEW RISK FACTORS AND TARGETS FOR THERAPY.NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES. VOL. 17. ISSUE 8. P. 565-571 | 26 | 93% | 18 |
Classes with closest relation at Level 1 |